Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Immunology | Hematology

Non-Hodgkin's Lymphoma Clinical Trials

A listing of Non-Hodgkin's Lymphoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

Children's Hospital of Alabama
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Birmingham Alabama 35213

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

University of Alabama at Birmingham
Birmingham Alabama 35294-3300

Patients are needed to participate in a clinical research study evaluating brentuximab vedotin and rituximab for the treatment of Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin or Lymphoma, T-Cell

University of Alabama at Birmingham
Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

View More »

University of Alabama at Birmingham
Birmingham Alabama 35294-3300

Patients are needed to participate in a clinical research study for the treatment of Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin or Lymphoma, T-Cell

University of Alabama at Birmingham
Birmingham Alabama 35294-3300

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

University of Alabama at Birmingham / Children's Hospital of Alabama
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

TG Therapeutics Investigational Trial Site
Huntsville Alabama 35805

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Clearview Cancer Institute
Huntsville Alabama 35805

A clinical trial seeking patients for a research study for the treatment of B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Waldenstrom Macroglobulinemia

Clearview Cancer Institute
Huntsville Alabama 35805

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

Clearview Cancer Institute
Huntsville Alabama 35805

A Phase 3 clinical study for patients with Indolent Non-Hodgkin's Lymphomas

University of South Alabama
Mobile Alabama 36604

A clinical trial to evaluate treatments using Arm A: Rituximab and Arm B: GA101 for patients with Indolent Non-Hodgkin's Lymphoma

Mobile Alabama

A Phase 2 clinical study for patients with Indolent Non-Hodgkin Lymphoma

Arizona

Ironwood Cancer and Research Center
Chandler Arizona 85224

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

GSK Investigational Site
Chandler Arizona 85224

A Phase 2 clinical study for patients with Lymphoma, Non-Hodgkin

Ironwood Cancer and Research Center
Chandler Arizona 85224

A Phase 3 clinical study for patients with Indolent Non-Hodgkin's Lymphomas

Southwest Cancer Care Medical Group
Glendale Arizona 85306
Updated

Patients are needed to participate in a clinical research study of Rituximab, Lenalidomide and Placebo to evaluate Lymphoma, Non-Hodgkin

Arizona Center for Cancer Care
Glendale Arizona 85306
Updated

Patients are needed to participate in a clinical research study of Rituximab, Lenalidomide and Placebo to evaluate Lymphoma, Non-Hodgkin

View More »

Arizona Oncology Associates, PC - HAL
Phoenix Arizona 85016
Updated

A clinical research study for the treatment of Lymphoma, B-cell or Lymphoma, Large B-cell, Diffuse

Phoenix Children's Hospital
Phoenix Arizona

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Mayo Clinic Arizona
Scottsdale Arizona 85259

A clinical trial seeking patients for a research study for the treatment of Cancer

Scottsdale Healthcare Research Institute
Scottsdale Arizona 85258

A clinical trial seeking patients for a research study for the treatment of Cancer

Mayo Clinic
Scottsdale Arizona 85259-5499

A clinical trial seeking patients for a research study of CB-839 for the treatment of Hematological Tumors

Mayo Clinic-Arizona
Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Arm A: Rituximab and Arm B: GA101 for patients with Indolent Non-Hodgkin's Lymphoma

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Mayo Clinic Arizona
Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Arizona Oncology Associates
Tucson Arizona 85745

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Arizona Clinical Research Center
Tucson Arizona 85715

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

University of Arizona (SPORE)
Tucson Arizona 85719

A clinical trial seeking patients for a research study for the treatment of B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Waldenstrom Macroglobulinemia

Site Reference ID/Investigator# 52902
Tucson Arizona 85724-5024
Updated

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Arizona Oncology Associates
Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Site Reference ID/Investigator# 97498
Tucson Arizona 85724-5024
Updated

Patients are needed to participate in a clinical research study of ABT-199 and Ketoconazole to evaluate Non-Hodgkin's Lymphoma

GSK Investigational Site
Tucson Arizona 85715

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Arkansas

Highlands Oncology Group
Bentonville Arkansas 72712

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Highlands Oncology Group
Fayetteville Arkansas 72703

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

The University of Arkansas for Medical Sciences
Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating SNS01-T

Rogers Arkansas 72758

Patients are needed to participate in a clinical research study evaluating bendamustine and RO5072759 for the treatment of Non-Hodgkin's Lymphoma

California

Anaheim California 90801

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Comprehensive Blood and Cancer Center (Bakersfield)
Bakersfield California 93309

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

Comprehensive Blood and Cancer Center (Bakersfield)
Bakersfield California 93309

A Phase 3 clinical study for patients with Indolent Non-Hodgkin's Lymphomas

Bellflower California 90706

Patients are needed to participate in a clinical research study evaluating bendamustine and RO5072759 for the treatment of Non-Hodgkin's Lymphoma

Providence Saint Joseph Medical Center
Burbank California 91505

A clinical trial seeking patients for a research study for the treatment of Relapsed Peripheral T-Cell Lymphoma or Refractory Peripheral T-Cell Lymphoma

View More »

GSK Investigational Site
Burbank California 91505

A Phase 2 clinical study for patients with Lymphoma, Non-Hodgkin

City of Hope Department of Hematology and Hematopoietic Cell Transplantation
Duarte California 91010-3000
Updated

A clinical research study for the treatment of Lymphoma, B-cell or Lymphoma, Large B-cell, Diffuse

City of Hope
Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of B-cell Non-Hodgkin Lymphoma

City of Hope
Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Marginal Zone Lymphoma or B-cell Lymphoma

City of Hope
Duarte California 91010
Updated

A clinical trial to evaluate treatments using Ibrutinib, DA-EPOCH-R and Ibrutinib, Lenalidomide, DA-EPOCH-R for patients with Diffuse Large B Cell Lymphoma Relapsed or Diffuse Large B Cell Lymphoma Refractory

City of Hope Cancer Center
Duarte California 91010

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

City of Hope
Duarte California 91010-3000

Patients are needed to participate in a clinical research study evaluating brentuximab vedotin and rituximab for the treatment of Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin or Lymphoma, T-Cell

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last